Arkolith/Insider Trading/GYRE/Form 4

Ma Songjiang

President, DirectorGYRE THERAPEUTICS, INC. (GYRE) · full profile →Form 4 · filed Mar 11, 2025
Net Selling
Open-Market Buys
$0
Open-Market Sells
$41K
Net Open-Market Flow
-$41K
Transactions
4
4 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Mar 10, 2025Sell(S)2K$10.14$20K2.8M
Mar 7, 2025Sell(S)53$13.03$6912.8M
Mar 7, 2025Sell(S)2K$10.13$19K2.8M
Mar 7, 2025Sell(S)41$12.14$4982.8M

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001140361-25-008091) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML